Health Issues

Home

 

Prostate cancer treatments

 

Prostate cancer treatments

  Prostate cancer is the most commonly diagnosed non-skin cancer in the United States. One in six American men will develop prostate cancer in the course of his lifetime. A little-known fact is that a man is 33% more likely to develop prostate cancer than an American woman is to get breast cancer.

These and other sobering facts are the driving forces of the Prostate Cancer Foundation, whose mission is to support research into better treatments and a cure for recurrent prostate cancer. The PCF is the world's largest source of philanthropic support for prostate cancer research. The PCF has raised more than $230 million to fund over 1,200 research projects, all with the goal of finding better treatments and a cure as soon as possible.

Prostate Cancer And You
Every man diagnosed with prostate cancer begins a deeply personal journey for himself and his loved ones in determining the appropriate therapy for the disease. Receiving a diagnosis of cancer is always very difficult. Prostate cancer is particularly complicated due to the variety of treatment options and the lack of knowledge, in certain cases, as to the most appropriate treatment. However, learning more about the disease, understanding the treatment options and their risks and benefits, and discovering the diet and lifestyle changes that may improve the prognosis all can help empower patients. It lets them participate more actively in their care and helps in making informed choices about treatment options.

prostate cancer that anyone concerned about or diagnosed with prostate cancer should know. It is impossible, however, to present all the information that might be relevant to a particular diagnosis.

 

No single cause of prostate cancer has been identified.  There are likely a variety of causes and contributing factors that lead to prostate cancer.  The major known risk factors for prostate cancer are age, race and family history.  Although there are no conclusive data, diet and other environmental factors may play a role as well.

Age
Age is the single most important factor in the development of prostate cancer.  It is extremely rare for a man under the age of 40 to develop detectable prostate cancer.  However, early growth of precancerous or cancerous cells in the prostate may actually begin before that time.  Detectable prostate cancer takes time to develop.   The chance of having prostate cancer increases rapidly after age 50.  In fact, about 80% of all prostate cancers are diagnosed in men over the age of 65.  A man in his mid-to-late seventies is 130 times more likely to develop prostate cancer than a man in his mid-to-late forties.  It is still unclear why prostate cancer rates increase with age; however, the genetic mutations that have been linked to development of cancer occur gradually over time.
 

Family History
Approximately 25% of men with prostate cancer have a history of the disease within their family.  However, it is believed that only 9% of all prostate cancers are purely hereditary.  The picture may be more complex for those patients with a family history since family members typically share other risk factors, including race, diet and other environmental factors.  The risk of prostate cancer doubles among men having a first-degree relative with the disease.  With two close relatives, a man's risk increases fivefold, and with three or more close relatives, the risk for developing prostate cancer is alarmingly high – close to 100%.

Diet, Obesity & Nutrition  
Diet and weight may play a role in the development of prostate cancer.  High intake of animal fats, such as those found in red meat, and polyunsaturated fats (corn oil, safflower oil, margarine, etc.) may be associated with higher rates of prostate cancer; however, it is unclear exactly how dietary fat might relate to increased risk.

 

Nutrition
Nutrition may play an important role in the prevention of prostate cancer.   Fruits and vegetables, especially cooked tomatoes, contain key sources of cancer-fighting agents, such as lycopene, antioxidants and fiber
Circulating Male Hormone Level
Lifetime risk of prostate cancer may be linked to the amount of the male hormone testosterone circulating in a man's body as early as puberty or even in utero, although direct evidence of this link remains to be shown.  Prostate cancer cell growth may be fueled by the presence of testosterone.  Therefore, one of the most common treatments for prostate cancer, especially if it returns after first-line treatment, is the complete suppression of testosterone production and action in the body.